Address
304 North Cardinal St.
Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
Levofloxacin lactate is a quinolone antibiotic. In 1986, Japan Daiichi Pharmaceutical Co., Ltd. successfully developed a new quinolone drug Levofloxacin for the first time, and in 1993, it was marketed in Japan as a tablet. China began to develop levofloxacin lactate in 1994, in July 1997, the raw material of Levofloxacin lactate was approved (approval number: National medicine approval number H10970044), suitable for sensitive bacteria caused by bronchial infection, lung infection, the main adverse reactions have gastrointestinal symptoms.
Indications:
Levofloxacin lactate is suitable for sensitive bacteria caused by:
1. Urinary and reproductive system infections, including simple, complex urinary tract infections, bacterial prostatitis, Neisseria gonorrhoeae urethritis or cervicitis (including those caused by enzyme producing strains).
2. Respiratory infections, including acute episodes of bronchial infection and pulmonary infection caused by sensitive gram-negative bacilli.
3. Gastrointestinal infection caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, aeromonas hydrophila, Vibrio parahaemolyticus, etc.
4. Typhoid fever.
5. Bone and joint infections. 6. Skin and soft tissue infection. 7. Systemic infections such as sepsis.
